The cytotoxic effects of ibrutinib were enhanced in vitro by the presence of inhibitors targeting breast cancer resistance protein, encoded by ABCG2, and P-glycoprotein, P-gp, encoded by ABCB1 [10]. Here, ABCB1 is linked to breast cancer.